BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
301381 Sailvan Times
- 22.38
- -0.96-4.11%
Market Closed May 15 15:00 CST
8.95BMarket Cap51.10P/E (TTM)
24.50High22.29Low144.36KlotVolume23.22Open23.34Pre Close335.37MTurnover7.51%Turnover Ratio41.83P/E (Static)400.10MShares32.8052wk High3.54P/B4.30BFloat Cap16.4952wk Low28.01Limit Up192.30MShs Float52.47Historical High18.67Limit Down9.47%Amplitude16.49Historical Low0.55Dividend TTM23.23Avg Price77.48KlotAsk2.46%Div YieldTTM100Lot Size60.98KlotBid
Sailvan Times Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 36.65%2.46B | 56.55%10.28B | 55.50%6.8B | 50.65%4.18B | 44.66%1.8B | 33.70%6.56B | 30.27%4.37B | 26.39%2.77B | 22.81%1.24B | -11.78%4.91B |
| Operating revenue | 36.65%2.46B | 56.55%10.28B | 55.50%6.8B | 50.65%4.18B | 44.66%1.8B | 33.70%6.56B | 30.27%4.37B | 26.39%2.77B | 22.81%1.24B | -11.78%4.91B |
| Other operating revenue | ---- | 62.91%49.47M | ---- | 99.37%22.61M | ---- | 181.81%30.36M | ---- | 307.68%11.34M | ---- | 443.56%10.77M |
| Total operating cost | 40.99%2.39B | 62.50%9.98B | 60.17%6.55B | 50.81%3.89B | 43.98%1.69B | 32.56%6.14B | 30.91%4.09B | 27.59%2.58B | 23.71%1.18B | -9.29%4.63B |
| Operating cost | 45.12%1.38B | 62.53%5.78B | 57.47%3.75B | 47.62%2.23B | 40.68%950.47M | 31.11%3.55B | 102.57%2.38B | 97.69%1.51B | 92.93%675.61M | 30.91%2.71B |
| Operating tax surcharges | 9.19%2.66M | 47.05%10.81M | 48.26%8.49M | 45.25%4.88M | 16.32%2.43M | -10.17%7.35M | -5.44%5.73M | -20.56%3.36M | -40.96%2.09M | 50.78%8.18M |
| Operating expense | 37.56%939.35M | 65.78%3.88B | 66.16%2.58B | 55.78%1.53B | 53.55%682.87M | 35.03%2.34B | -15.69%1.56B | -17.09%980.91M | -19.95%444.73M | -38.28%1.73B |
| Administration expense | 34.85%50.3M | 41.91%219.36M | 39.36%143.79M | 49.25%87.4M | 24.51%37.3M | 10.69%154.58M | 17.92%103.18M | 1.72%58.56M | 11.57%29.96M | -2.92%139.64M |
| Financial expense | -48.03%-10.14M | -550.63%-28.41M | -206.31%-15.36M | -161.42%-18.46M | -172.78%-6.85M | 42.13%-4.37M | 70.65%-5.02M | -16.12%-7.06M | 50.31%9.41M | -117.98%-7.54M |
| -Interest expense (Financial expense) | 108.63%7.93M | 61.20%22.55M | 32.89%13.46M | 16.68%7.57M | 20.10%3.8M | -4.04%13.99M | -8.20%10.13M | -12.64%6.49M | -13.89%3.16M | 9.12%14.58M |
| -Interest Income (Financial expense) | 22.46%-1.74M | -36.35%-12.25M | -43.47%-9.31M | -52.62%-4.73M | -10.38%-2.24M | -626.60%-8.98M | -772.07%-6.49M | -872.82%-3.1M | -924.83%-2.03M | -247.44%-1.24M |
| Research and development | -2.99%27.09M | 35.65%118.95M | 60.98%82.15M | 78.58%54.87M | 88.34%27.92M | 84.17%87.69M | 83.21%51.03M | 72.83%30.72M | 70.21%14.83M | 32.09%47.61M |
| Credit Impairment Loss | -1,090.29%-1.65M | -75.46%-5.52M | 12.21%-573.74K | -208.39%-1.44M | 58.65%-139.03K | -91.78%-3.14M | -256.09%-653.54K | -211.52%-466.93K | -171.79%-336.21K | 86.09%-1.64M |
| Asset Impairment Loss | 21.27%-21.15M | -26.69%-85.33M | -43.77%-69.37M | -52.39%-46.64M | -83.72%-26.86M | 14.33%-67.36M | 20.85%-48.25M | 16.73%-30.61M | 19.57%-14.62M | -12.54%-78.62M |
| Other net revenue | -283.04%-15.14M | -24.76%-40.4M | 12.66%-24.95M | 43.24%-10.67M | 35.72%-3.95M | 47.81%-32.38M | 46.72%-28.56M | 39.63%-18.79M | 54.31%-6.15M | -23.35%-62.04M |
| Fair value change income | -32.40%2.93M | 118.30%1.58M | 267.80%13.3M | 332.05%11.49M | 493.55%4.33M | ---8.64M | ---7.93M | ---4.95M | ---1.1M | ---- |
| Invest income | -46.91%3.2M | 42.21%27.61M | 22.48%17.17M | 115.68%12.86M | 121.38%6.03M | 7,621.19%19.42M | 4,451.97%14.02M | 680.19%5.96M | 48.70%2.72M | -93.49%251.47K |
| -Including: Investment income associates | ---- | ---- | ---- | ---- | ---- | -78.14%171.16K | -28.58%254.79K | -24.48%269.43K | -40.41%94.06K | 22.49%783.02K |
| Asset deal income | ---- | 143.41%9.16M | 196.32%11.12M | 173.64%10.16M | 177.66%10.15M | -34.72%3.76M | 88.85%3.75M | 87.08%3.71M | --3.66M | 851.53%5.77M |
| Other revenue | -39.47%1.54M | -48.68%12.1M | -67.65%3.39M | -61.55%2.91M | -27.95%2.54M | 93.17%23.57M | 99.41%10.49M | 77.68%7.56M | 17.04%3.53M | -55.52%12.2M |
| Operating profit | -45.97%54.52M | -34.55%255.19M | -11.41%227.16M | 58.37%275.68M | 65.85%100.91M | 82.19%389.89M | 42.00%256.43M | 23.77%174.07M | 26.58%60.84M | -47.39%214.01M |
| Add:Non operating Income | 395.32%899.02K | 104.16%1.36M | 172.09%1.49M | 40.26%540.45K | -35.89%181.5K | -33.13%665.25K | -46.42%546.88K | 76.12%385.32K | 94.23%283.13K | -63.30%994.91K |
| Less:Non operating expense | -68.19%792.06K | 130.73%6.8M | 87.23%5.89M | 36.38%4.18M | 44.09%2.49M | -19.63%2.95M | 24.60%3.14M | 38.97%3.06M | 170.68%1.73M | 67.14%3.67M |
| Total profit | -44.59%54.63M | -35.57%249.75M | -12.24%222.76M | 58.72%272.05M | 66.00%98.6M | 83.41%387.61M | 41.74%253.83M | 23.61%171.4M | 24.85%59.4M | -48.11%211.33M |
| Less:Income tax cost | -39.43%7.6M | -31.53%35.65M | -12.54%27.35M | 73.27%36.46M | 68.98%12.56M | 95.91%52.06M | 41.98%31.28M | 16.23%21.04M | -11.23%7.43M | -55.38%26.57M |
| Net profit | -45.35%47.03M | -36.19%214.1M | -12.20%195.41M | 56.69%235.59M | 65.58%86.04M | 81.62%335.55M | 41.71%222.55M | 24.72%150.35M | 32.56%51.97M | -46.87%184.76M |
| Net profit from continuing operation | -45.35%47.03M | -36.19%214.1M | -12.20%195.41M | 56.69%235.59M | 65.58%86.04M | 81.62%335.55M | 41.71%222.55M | 24.72%150.35M | 32.56%51.97M | -46.87%184.76M |
| Net profit of parent company owners | -45.35%47.03M | -36.19%214.1M | -12.20%195.41M | 56.69%235.59M | 65.58%86.04M | 81.62%335.55M | 41.71%222.55M | 24.72%150.35M | 32.56%51.97M | -46.87%184.76M |
| Earning per share | ||||||||||
| Basic earning per share | -45.37%0.1175 | -39.92%0.5351 | -19.05%0.4884 | 41.00%0.5888 | 48.96%0.2151 | 73.56%0.8907 | 38.31%0.6033 | 24.69%0.4176 | 32.60%0.1444 | -46.87%0.5132 |
| Diluted earning per share | -45.37%0.1175 | -39.92%0.5351 | -19.05%0.4884 | 41.00%0.5888 | 48.96%0.2151 | 73.56%0.8907 | 38.31%0.6033 | 24.69%0.4176 | 32.60%0.1444 | -46.87%0.5132 |
| Other composite income | -161.35%-417.57K | 21,611.16%1.91M | -50.91%-1.49M | 67.80%-368.09K | 57.59%-159.77K | -100.25%-8.86K | -4.73%-989.37K | -152.31%-1.14M | -592.40%-376.77K | 456.78%3.54M |
| Other composite income of parent company owners | -161.35%-417.57K | 21,611.16%1.91M | -50.91%-1.49M | 67.80%-368.09K | 57.59%-159.77K | -100.25%-8.86K | -4.73%-989.37K | -152.31%-1.14M | -592.40%-376.77K | 456.78%3.54M |
| Total composite income | -45.73%46.61M | -35.62%216M | -12.48%193.91M | 57.64%235.22M | 66.48%85.89M | 78.20%335.54M | 41.93%221.56M | 21.57%149.21M | 31.78%51.59M | -45.69%188.3M |
| Total composite income of parent company owners | -45.73%46.61M | -35.62%216M | -12.48%193.91M | 57.64%235.22M | 66.48%85.89M | 78.20%335.54M | 41.93%221.56M | 21.57%149.21M | 31.78%51.59M | -45.69%188.3M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.